Prospective Validation of the Prognostic Relevance of CD34+CD38- AML Stem Cell frequency in the HOVON-SAKK132 trial.
Options
BORIS DOI
Publisher DOI
PubMed ID
36898087
Date of Publication
2023-05-25
Publication Type
Article
Subject(s)
Language(s)
en
Contributor(s)
Ngai, Lok Lam | |
Hanekamp, Diana | |
Janssen, Fleur | |
Carbaat-Ham, Jannemieke | |
Hofland, Maaike A M | |
Fayed, Mona M H E | |
Kelder, Angèle | |
Oudshoorn-van Marsbergen, Laura | |
Scholten, Willemijn J | |
Snel, Alexander N | |
Bachas, Costa | |
Tettero, Jesse M | |
Breems, Dimitri A | |
Fischer, Thomas | |
Gjertsen, Bjorn T | |
Griskevicius, Laimonas | |
Juliusson, Gunnar | |
van de Loosdrecht, Arjan A | |
Maertens, Johan A | |
Manz, Markus G | |
Passweg, Jakob R | |
Porkka, Kimmo | |
Valk, Peter J M | |
Gradowska, Patrycja | |
Löwenberg, Bob | |
de Leeuw, David C | |
Janssen, Jeroen J W M | |
Ossenkoppele, Gert J | |
Cloos, Jacqueline |
Additional Credits
Series
Blood
Publisher
American Society of Hematology
ISSN
1528-0020
Access(Rights)
restricted